282 related articles for article (PubMed ID: 17492605)
1. Isoniazid activity is terminated by bacterial persistence.
Mitchison DA; Jindani A; Davies GR; Sirgel F
J Infect Dis; 2007 Jun; 195(12):1871-2; author reply 1872-3. PubMed ID: 17492605
[No Abstract] [Full Text] [Related]
2. Persistence, not resistance, is the cause of loss of isoniazid effect.
Wallis RS; Palaci M; Eisenach K
J Infect Dis; 2007 Jun; 195(12):1870-1; author reply 1872-3. PubMed ID: 17492604
[No Abstract] [Full Text] [Related]
3. Transmission of isoniazid-resistant tuberculosis.
Borgdorff MW
J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
[No Abstract] [Full Text] [Related]
4. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
[TBL] [Abstract][Full Text] [Related]
5. [Antibacterial effectiveness of long-acting isoniazid in the experiment].
Shkurupií VA; Kurunov IN; Arkhipov SA
Probl Tuberk; 1997; (2):54-6. PubMed ID: 9235596
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
[No Abstract] [Full Text] [Related]
7. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance in tuberculosis.
Ebrahim GJ
J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
[No Abstract] [Full Text] [Related]
9. Genetic diversity of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Poland and assessed by spoligotyping.
Augustynowicz-Kopec E; Jagielski T; Zwolska Z
J Clin Microbiol; 2008 Dec; 46(12):4041-4. PubMed ID: 18832130
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of bactec MGIT 960 AST and conventional proportion method using Ogawa medium for the drug susceptibility testing of Mycobacterium tuberculosis to isoniazid].
Mitarai S; Kobayashi I; Abe C; Wada M; Suzuki K; Takashima T; Kawabe Y; Machida K; Tano M; Takigawa S; Kamada A; Shigetoh E; Fujii S; Mori K; Suyama H; Yano S; Kawashiro T; Ogata H
Kekkaku; 2007 May; 82(5):449-54. PubMed ID: 17564123
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.
Sriram D; Yogeeswari P; Yelamanchili Priya D
Biomed Pharmacother; 2009 Jan; 63(1):36-9. PubMed ID: 18343086
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity.
Yadav AB; Misra A
Antimicrob Agents Chemother; 2007 Oct; 51(10):3740-2. PubMed ID: 17664326
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
[TBL] [Abstract][Full Text] [Related]
14. Reliability of Mycobacterial Growth Indicator Tube (MGIT) 960 for the detection of isoniazid resistance in a tuberculosis endemic setting.
Gomathi NS; Kumar V
Indian J Med Res; 2014 Mar; 139(3):471-3. PubMed ID: 24820845
[No Abstract] [Full Text] [Related]
15. [Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].
Afanas'ev MV; Ikriannikova LN; Il'ina EN; Smirnova TG; Larionova EE; Kuz'min AV; Chernousova LN; Kamaev EIu; Skorniakov SN; Kinsht VN; Cherednichenko AG; Govorun VM
Probl Tuberk Bolezn Legk; 2007; (7):37-42. PubMed ID: 17722291
[No Abstract] [Full Text] [Related]
16. Analysis of the role of Mycobacterium tuberculosis kasA gene mutations in isoniazid resistance.
Sun YJ; Lee AS; Wong SY; Paton NI
Clin Microbiol Infect; 2007 Aug; 13(8):833-5. PubMed ID: 17501974
[TBL] [Abstract][Full Text] [Related]
17. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
Sacchettini JC; Rubin EJ; Freundlich JS
Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
[TBL] [Abstract][Full Text] [Related]
18. Expanding the role of the microscopic observation drug susceptibility assay in tuberculosis and HIV management.
Minion J; Pai M
Clin Infect Dis; 2010 Apr; 50(7):997-9. PubMed ID: 20192726
[No Abstract] [Full Text] [Related]
19. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
Matee M; Mfinanga S; Holm-Hansen C
APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
[TBL] [Abstract][Full Text] [Related]
20. [Reasons for drug-resistant tuberculosis emergence].
Tu DH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
[No Abstract] [Full Text] [Related]
[Next] [New Search]
